Examples of currently approved anti-inflammatory therapies that target metabolism include metformin (targeting mTOR, used for the treatment of type 2 diabetes), rapamycin (targeting AMPK and ETC complex I, used as an immunosuppressive drug), and DMF (antioxidant and enhancer of mitochondrial respiration) [231]. This evidence concerns the gene MTOR and type 2 diabetes mellitus.